School of Medicine
Showing 3,551-3,600 of 13,036 Results
-
Kristen N Ganjoo
Professor of Medicine (Oncology)
Current Research and Scholarly InterestsGiant cell tumor of the bone
Gastrointestinal stromal tumors
Soft tissue sarcoma
Osteosarcoma -
Hayley Gans
Clinical Professor, Pediatrics - Infectious Diseases
Current Research and Scholarly InterestsThe focus of my laboratory is the immune response to viral vaccines evaluating the ontogeny of responses in infants and limitations in immunocompromised hosts. We have studied responses to an early two-dose measles immunization, one versus 2 doses of varicella immunization, and polio vaccine in preterm versus term infants. Other active areas of research include measles and varicella immunity in HIV infected individuals, and transplant recipients.
-
Alex Gao
Assistant Professor of Biochemistry and of Microbiology and Immunology
Current Research and Scholarly InterestsWe integrate computational genome mining with high-throughput experimental approaches and structural biology to harness the rich diversity of genes from microbes, with the goal of developing new antibiotic strategies and molecular biotechnology. A major area of current interest is uncovering novel molecular functions involved in anti-phage defense and bacteria–phage interactions, which are a major driver of molecular innovation in nature.
-
Xiaojing Gao
Assistant Professor of Chemical Engineering
Current Research and Scholarly InterestsHow do we design biological systems as “smart medicine” that sense patients’ states, process the information, and respond accordingly? To realize this vision, we will tackle fundamental challenges across different levels of complexity, such as (1) protein components that minimize their crosstalk with human cells and immunogenicity, (2) biomolecular circuits that function robustly in different cells and are easy to deliver, (3) multicellular consortia that communicate through scalable channels, and (4) therapeutic modules that interface with physiological inputs/outputs. Our engineering targets include biomolecules, molecular circuits, viruses, and cells, and our approach combines quantitative experimental analysis with computational simulation. The molecular tools we build will be applied to diverse fields such as neurobiology and cancer therapy.
-
Yifan Gao
Postdoctoral Scholar, Microbiology and Immunology
BioDr. Yifan Gao is a postdoctoral researcher at Stanford University School of Medicine in the Department of Microbiology and Immunology under Prof. Justin Sonnenburg's advisement. Prior to joining Stanford, she received her Ph.D. from UCLA focusing on Environmental Microbiology and M.S. from UC Berkeley in Environmental Engineering.
-
Adrené Garabedian
Engagement Programs Manager, Emergency Medicine
Current Role at StanfordEmergency Medicine Strategy Manager
Faculty & Staff Engagement Program Manager & Co-Lead -
Zainab Garba-Sani
Affiliate, Health Policy
BioZainab Garba-Sani is a Stanford-affiliated Research Scholar and UK Commonwealth Fund Senior Harkness Fellow (2022–23), working at the intersection of health policy, science, and community-centred practice. Her work focuses on how emerging fields such as artificial intelligence, genomics, and regenerative medicine can be translated responsibly into real-world health impact - particularly for underserved populations and people living with chronic and rare conditions.
Her research and practice are grounded in bridging cutting-edge science and innovation with lived experience - focusing on inclusive design, governance, and real-world implementation. She is the founder of ACCESS AI, an initiative advancing equitable and inclusive approaches to health AI through diverse community engagement, meaningful co-production, and interdisciplinary collaboration. Through this work, she contributes to broader conversations on AI governance, data equity, and the societal implications of innovation.
Alongside this, Garba-Sani collaborates internationally with academic institutions, healthcare systems, civil society, industry, and governments to strengthen innovation pathways and care models for sickle cell and other historically neglected populations, including in low-and middle- income countries. She holds senior advisory and leadership roles across health and research ecosystems and is an advisor to multiple committees focused on gene and cell therapies, regenerative medicine, health equity, and rare diseases. She is Vice Chair of the Sickle Cell Society and was recently the Founding Chair of NHS England’s Sickle Cell Transformation Patient Advisory Group and Co-Chair of Genomics England’s Diverse Data Advisory Board.
Garba-Sani holds an MSc in Health Policy from Imperial College London and brings extensive experience in healthcare leadership, having previously served in senior roles at NHS England, TEDxNHS, and the NHS Muslim Network. Her contributions have been recognised with numerous awards, including the UK Prime Minister’s Points of Light Award. -
Alan M. Garber
Henry J. Kaiser Jr. Professor and Professor of Medicine, Emeritus
Current Research and Scholarly InterestsTopics in the health economics of aging; health, insurance; optimal screening intervals; cost-effectiveness of, coronary surgery in the elderly; health care financing and delivery, in the United States and Japan; coronary heart disease
-
Cathy Garcia
Postdoctoral Scholar, Stanford Cancer Institute
Current Research and Scholarly InterestsIslet biology, diabetes, obesity, pancreatic cancer
-
Chris Garcia
Younger Family Professor and Professor of Structural Biology
Current Research and Scholarly InterestsStructural and functional studies of transmembrane receptor interactions with their ligands in systems relevant to human health and disease - primarily in immunity, infection, and neurobiology. We study these problems using protein engineering, structural, biochemical, and combinatorial biology approaches.
-
Gabriel Garcia, MD
Professor of Medicine (Gastroenterology and Hepatology) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsThe natural history of common viral liver diseases of man is poorly understood, despite the fact that chronic liver diseases of man may result in death from liver failure or hepatocellular carcinoma.
-
Patricia Garcia
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioPatricia Garcia, MD is a board certified gastroenterologist and clinical informaticist. She is fellowship trained in neurogastroenterology and specializes in treating disorders of gastrointestinal motility including trouble swallowing, heartburn, reflux, constipation, fecal incontinence and pelvic floor dysfunction. She is also passionate about using digital health technologies and artificial intelligence to improve clinician and care team burden and burnout.
-
Leonor García-Bayona
Assistant Professor of Microbiology and Immunology
Current Research and Scholarly InterestsThe human microbiome is evolving rapidly (i.e. over our lifetimes) following changes in modern lifestyles, especially in industrialized countries. The García-Bayona lab seeks to understand how horizontal gene transfer shapes interactions within the human intestinal microbiota and what the implications of this widespread phenomenon are for community properties relevant to human health (for example, the ability of the gut community to recover after antibiotic treatment). There is currently only a superficial understanding of the different cellular roles of most exchanged genes, the mechanisms governing their spread and their effect community dynamics. Our lab works on bridging the existing gap between the current systems-level observational studies and a mechanistic understanding through bacterial genetics and physiology. We take a bottom-up approach (from genes to communities), incorporating genetics, metagenomics, population analyses and experimental evolution in tractable bacterial consortia.
-
Manuel Garcia-Careaga
Clinical Professor Emeritus (Active), Pediatrics - Gastroenterology
Current Research and Scholarly InterestsGastroenterology, liver disease in cystic fibrosis patients, percutaneous gastrostomy tube in pediatric population, inflamatory bowel disease, failure to thrive
